274 related articles for article (PubMed ID: 16565222)
1. Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrow.
Bomken SN; Redfern K; Wood KM; Reid MM; Tweddle DA
J Clin Pathol; 2006 Sep; 59(9):927-9. PubMed ID: 16565222
[TBL] [Abstract][Full Text] [Related]
2. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
[TBL] [Abstract][Full Text] [Related]
4. Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin.
Krishnan C; Twist CJ; Fu T; Arber DA
Am J Clin Pathol; 2009 Jan; 131(1):49-57. PubMed ID: 19095565
[TBL] [Abstract][Full Text] [Related]
5. Detection of metastatic neuroblastoma in bone marrow biopsy specimens with an antibody to neuron-specific enolase.
Crary GS; Singleton TP; Neglia JP; Swanson PE; Strickler JG
Mod Pathol; 1992 May; 5(3):308-11. PubMed ID: 1495935
[TBL] [Abstract][Full Text] [Related]
6. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
[TBL] [Abstract][Full Text] [Related]
7. Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.
Gretschel S; Astrosini Ch; Vieth M; Jöns T; Tomov T; Höcker M; Schlag PM; Kemmner W
Eur J Surg Oncol; 2008 Jun; 34(6):642-7. PubMed ID: 18023552
[TBL] [Abstract][Full Text] [Related]
8. [Detection of residual cells contaminating the bone marrow in neuroblastoma. Apropos of 80 bone marrow evaluations].
Frappaz D; Maritaz O; Favrot MC; Philip I; Bernard JL; Bailly C; Gentilhomme O; Gentet JC; Zucker JM; Bouffet E
Arch Fr Pediatr; 1987 Nov; 44(9):771-8. PubMed ID: 3446068
[TBL] [Abstract][Full Text] [Related]
9. NB84: a new monoclonal antibody for the recognition of neuroblastoma in routinely processed material.
Thomas JO; Nijjar J; Turley H; Micklem K; Gatter KC
J Pathol; 1991 Jan; 163(1):69-75. PubMed ID: 2002424
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow involvement by metastatic solid tumors.
Sharma S; Murari M
Indian J Pathol Microbiol; 2003 Jul; 46(3):382-4. PubMed ID: 15025279
[TBL] [Abstract][Full Text] [Related]
11. Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C; Higgins JP; West RB; Natkunam Y; Heerema-McKenney A; Arber DA
Am J Surg Pathol; 2009 Nov; 33(11):1695-704. PubMed ID: 19701075
[TBL] [Abstract][Full Text] [Related]
12. [Can detection of cancer cells in bone marrow and peripheral blood be used in diagnosis and patient monitoring?].
Werther K; Brünner NA; Nielsen HJ
Ugeskr Laeger; 1998 Oct; 160(41):5923-6. PubMed ID: 9786030
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
Kuroda T; Morikawa N; Matsuoka K; Fujino A; Honna T; Nakagawa A; Kumagai M; Masaki H; Saeki M
J Pediatr Surg; 2008 Dec; 43(12):2182-5. PubMed ID: 19040931
[TBL] [Abstract][Full Text] [Related]
14. [The morphological assessment of bone marrow infiltration in neuroblastoma].
Brisigotti M; Medicina D; Bercich L; Bonetti MF; Fabbretti G; Gambini C; Lo Piccolo MS; Milanaccio C; Rosanda C; Garaventa A; De Bernardi B; Callea F
Pediatr Med Chir; 1998; 20(3):169-74. PubMed ID: 9744007
[TBL] [Abstract][Full Text] [Related]
15. [MR imaging in patients with bone marrow metastases of neuroblastoma].
Kanegawa K; Nishiyama S; Koshino T; Mabuchi O; Muraji T
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):368-72. PubMed ID: 8710458
[TBL] [Abstract][Full Text] [Related]
16. [The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications].
Faulkner LB; Tamburini A; Tintori V; Paoli A; Tondo A; Bernini G; Medicina D; Brisigotti M; Corrias MV; Scaruffi P; Rosanda C; Lo Piccolo MS; Viscardi E; Milanaccio C; Garaventa A; De Bernardi B
Pediatr Med Chir; 1998; 20(3):175-8. PubMed ID: 9744008
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: preliminary report.
Nowicki M; Ostalska-Nowicka D; Miskowiak B
J Clin Pathol; 2006 Feb; 59(2):150-2. PubMed ID: 16443729
[TBL] [Abstract][Full Text] [Related]
18. Concomitant bone marrow metastasis of a glioblastoma multiforme revealed at the diagnosis.
Didelot A; Taillandier L; Grignon Y; Vespignani H; Beauchesne P
Acta Neurochir (Wien); 2006 Sep; 148(9):997-1000. PubMed ID: 16932995
[TBL] [Abstract][Full Text] [Related]
19. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.
Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N
Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
